Login

HealthBeacon CEO James Joyce discusses the company's €25m fundraising and going public on Euronext's growth market in Dublin with Proactive. 00:10:00

Share On Facebook Share On Twitter

The chief executive of HealthBeacon, Jim Joyce

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Transforming Healthcare: From Sick Care to Preventative Care | Teemu Suna, CEO , Nightingale Health Oyj.
00:10:00
Insights into Asset Management and Market Outlook | B.Gopkumar, CEO ,Axis Mutual Fund.
00:10:00
Mangold Insight interviews tech company DLTx, delving into discussions on AI competitiveness with a reference to C3.ai.
00:00:00
Sienna Cancer Diagnostics (ASX:SDX) talks IVD test sales - Matthew Hoskin, CEO, Sienna Cancer Diagnostics Ltd
00:10:00
Kumin-A Nickel Sulfide Project: Advancing Premium Class 1 Nickel Production
00:10:00
AI in Travel: Jane Sun on Transforming the Industry at Trip.com | Morgan Stanley
00:10:00
Highlands Pacific: Leveraging Papua New Guinea's Metals for the Battery Revolution
00:10:00
Crescendo Financial Group: Redefining Wealth Management Excellence | Autumn Sowders, CFP®, Crescendo Financial Group
00:10:00
Invests in fast-growing companies with global potential|Gina Kirsch,Founding Partner,The Venture Collective (TVC)
00:10:00
Invests in companies at the intersection of bio x data|Sara Choi,Partner,Wing Venture Capital
00:10:00
Invests in technical founders building the next generation of applications|Mike Dauber,General Partner,Amplify Partners
00:10:00
empower consumers to live on their terms|David Wu,General Partner,Maveron

© 2017 - Neuhu+